According to Tushar Mahajan - head of listed futures & options for India at Nomura Financial Advisory, one may prefer Glenmark Pharma.
first published: Apr 15, 2015 12:01 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

